ANIP vs DVA · rev $503.5M vs P/E 14, rev $6.97B
ANI Pharmaceuticals Inc (ANIP) versus DaVita HealthCare Partners Inc (DVA) — a side-by-side from cached financials, not a winner call.
ANI Pharmaceuticals Inc (ANIP) is a drug manufacturers - specialty & generic company listed on US.
DaVita HealthCare Partners Inc (DVA) is a medical care facilities company listed on US.
Latest reported ANIP revenue for 2026-06-30 was $503.5M. Net income was $54.2M. ANIP currently screens at market cap $1.41B.
Latest reported DVA revenue for 2026-06-30 was $6.97B. Net income was $462.9M. DVA currently screens at market cap $10.77B and trailing P/E 14.1.
ANIP currently screens at market cap $1.41B. DVA currently screens at market cap $10.77B and trailing P/E 14.1.
Not investment advice. Open the ANIP and DVA stock pages for the full models.
Not investment advice.